Cytokinetics News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.12.24	Why Cytokinetics Stock Was a Nearly 5% Winner Today (MotleyFool)
08.11.24	This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday (Benzinga)
09.09.24	Cytokinetics Sets Stage For Mid-Stage Study For Heart Failure Drug After Encouraging Data From Phase 1 Study (Benzinga)
23.05.24	Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe (Benzinga)
23.05.24	Why Cytokinetics (CYTK) Shares Are Falling (Benzinga)
23.05.24	VF Corp Posts Weak Q4 Results, Joins NetEase, Cytokinetics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session (Benzinga)
03.04.24	$100 Invested In Cytokinetics 5 Years Ago Would Be Worth This Much Today (Benzinga)
15.03.24	Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today (Benzinga)
28.02.24	Unpacking the Latest Options Trading Trends in Cytokinetics (Benzinga)
27.02.24	Here's How Much $1000 Invested In Cytokinetics 10 Years Ago Would Be Worth Today (Benzinga)
09.02.24	Here's How Much $1000 Invested In Cytokinetics 5 Years Ago Would Be Worth Today (Benzinga)
02.02.24	Here's How Much $100 Invested In Cytokinetics 5 Years Ago Would Be Worth Today (Benzinga)
12.01.24	Novartis bläst laut Insider mögliche Übernahme von Cytokinetics ab (Handelszeitung)
11.01.24	Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition (Benzinga)
09.01.24	What's Been Happening With Cytokinetics Stock? (Benzinga)
26.04.17	Las Vegas Sands Reports First Quarter 2017 Results (PR Newswire)
01.12.16	The Lancet Publishes Results From COSMIC-HF Trial Showing Omecamtiv Mecarbil Significantly Improved Cardiac Function In Patients With Chronic Heart Failure (PR Newswire)
18.08.16	JNP Will Bleed On Failed Trial, CERU Crashes, CYTK Progresses With VITALITY (RTTNews)
05.08.16	The Race To Cure Spinal Muscular Atrophy (RTTNews)
10.01.16	Cytokinetics Reports Presentation Of Exploratory Analyses Of Data From EMPOWER (RTTNews)
08.11.15	Amgen And Cytokinetics Announce Presentation Of Data From COSMIC-HF Trial (RTTNews)
28.10.15	Viral Therapy For Cancer Gets FDA Nod, ARNA Slimming Down, ZLTQ Well-Sculpted (RTTNews)
27.10.15	Amgen Reports Positive Top-Line Results From Omecamtiv Mecarbil Phase 2 Trial (RTTNews)
14.07.15	Cytokinetics Announces Start Of Phase 3 Trial Of Tirasemtiv In Patients With ALS (RTTNews)
16.10.13	Critical Alerts For SunPower, Starbucks, ACADIA Pharmaceuticals, Opko Health, and Cytokinetics Released By InvestorsObserver (PR Newswire)
13.09.13	Critical Alerts For IBM, Cytokinetics, Freeport McMoran, Portfolio Recovery Associates, and Spectra Energy Released By InvestorsObserver (PR Newswire)
03.09.13	Pre-market Movers For Sept 3 (MSFT, TSLA, CYTK, ISIS) (RTTNews)
03.09.13	CYTK To Take A Hit, Tune Into ESPR, Watch Out For HALO Effect (RTTNews)
22.08.13	Cytokinetics:PhaseII Trials Of Tirasemtiv In Patients With ALS'Results Published (RTTNews)
23.07.13	Pre-market Movers For July 23 (FIRE, NFLX, RSH, DD, ARRY, CSE, FTNT, PENN, CYTK) (RTTNews)
23.07.13	Cytokinetics Amends Protocol & Revises Guidance For BENEFIT-ALS - Quick Facts (RTTNews)
08.07.13	Pre-market Movers For July 8 (DELL, PCLN, BABY, CKSW, CYTK) (RTTNews)
08.07.13	Cytokinetics Issues Update On Conduct Of BENEFIT-ALS - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	28.46	2.63 %	K V
Swiss Life Hldg	712.60	1.86 %	K V
Part Grp Hldg	1’245.50	1.26 %	K V
Zurich Insur Gr	545.00	1.15 %	K V
Swiss Re	132.70	1.14 %	K V
Givaudan	3’945.00	-0.53 %	K V
Geberit	511.20	-0.66 %	K V
Alcon	76.38	-0.68 %	K V
Sika	212.90	-1.34 %	K V
CieFinRichemont	134.25	-2.65 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cytokinetics Inc.

Aktien Top/Flop

Meistgelesene Nachrichten